Focus on Alternative and Complementary Therapies
www.pharmpress.com/fact
Focus Alternat Complement Ther©2005 Pharmaceutical Press
Focus Altern Complement Ther 2006; 11: 46–7
Taurox has been reported to reduce fatigue in patients with HCV, cancer, post-lyme/chronic lyme disease, chronic fatigue syndrome and fibromyaligia. Clinical trials reported improvement in quality of life (QoL) measures in addition to a reduction in fatigue. However, clinical trials often report better results than post-marketing studies. We studied QoL benefit in home use, in a generally healthier population not subject to clinical trial selection and the attendant healing environment.
Taurox (Tauroxicum) is a homoeopathic remedy ingredient made from COBAT, a modified di-peptide containing beta-alanine and taurine. Taurox is administered in nanogram/day doses sub-lingually. Attempts were made to contact all persons purchasing Taurox products from CureImmune, Inc. during predefined periods. If the customer was there, a structured interview was conducted. In order to avoid reply selection bias, no message was left for customers who were not available at that time.
A total of 51 customers were reached in two calling periods. Some QoL measures were not reported to have changed. In comparison to these internal control measures, several specific measures of QoL were reported to be significantly improved. Fatigue was decreased in 80–85% of users; allergy symptoms and CNS symptoms (mood and ability to concentrate) improved in 40–75%.
Users of Taurox report significant QoL improvement in several QoL measures. Neuroimmunologic symptoms, especially fatigue, improved.
FindCure.Org provided all funding.
